Prostaglandin D 2 Added during the Differentiation of 3T3-L1 Cells Suppresses Adipogenesis via Dysfunction of D-Prostanoid Receptor P1 and P2.

We previously reported that the addition of prostaglandin, (PG)D 2 , and its chemically stable analog, 11-deoxy-11-methylene-PGD 2 (11d-11m-PGD 2 ), during the maturation phase of 3T3-L1 cells promotes adipogenesis. In the present study, we aimed to elucidate the effects of the addition of PGD 2 or 11d-11m-PGD 2 to 3T3-L1 cells during the differentiation phase on adipogenesis. We found that both PGD 2 and 11d-11m-PGD 2 suppressed adipogenesis through the downregulation of peroxisome proliferator-activated receptor gamma (PPARγ) expression. However, the latter suppressed adipogenesis more potently than PGD 2 , most likely because of its higher resistance to spontaneous transformation into PGJ 2 derivatives. In addition, this anti-adipogenic effect was attenuated by the coexistence of an IP receptor agonist, suggesting that the effect depends on the intensity of the signaling from the IP receptor. The D-prostanoid receptors 1 (DP1) and 2 (DP2, also known as a chemoattractant receptor-homologous molecule expressed on Th2 cells) are receptors for PGD 2 . The inhibitory effects of PGD 2 and 11d-11m-PGD 2 on adipogenesis were slightly attenuated by a DP2 agonist. Furthermore, the addition of PGD 2 and 11d-11m-PGD 2 during the differentiation phase reduced the DP1 and DP2 expression during the maturation phase. Overall, these results indicated that the addition of PGD 2 or 11d-11m-PGD 2 during the differentiation phase suppresses adipogenesis via the dysfunction of DP1 and DP2. Therefore, unidentified receptor(s) for both molecules may be involved in the suppression of adipogenesis.